IS7339A - Aðferð til framleiðslu á 7alfa-metýlsterum - Google Patents

Aðferð til framleiðslu á 7alfa-metýlsterum

Info

Publication number
IS7339A
IS7339A IS7339A IS7339A IS7339A IS 7339 A IS7339 A IS 7339A IS 7339 A IS7339 A IS 7339A IS 7339 A IS7339 A IS 7339A IS 7339 A IS7339 A IS 7339A
Authority
IS
Iceland
Prior art keywords
7alpha
producing
methyl esters
esters
methyl
Prior art date
Application number
IS7339A
Other languages
English (en)
Other versions
IS2740B (is
Inventor
Stoelwinder J.
Ostendorf M.
Van Buggenum P.A.M.
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of IS7339A publication Critical patent/IS7339A/is
Publication of IS2740B publication Critical patent/IS2740B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0085Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0088Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
IS7339A 2002-01-21 2004-06-28 Forskautsbygging rafgreiningarkera til þess að framleiða ál með tilheyrandi kerskála IS2740B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075230 2002-01-21
PCT/EP2003/000339 WO2003059931A1 (en) 2002-01-21 2003-01-14 PROCESS FOR THE PREPARATION OF 7α-METHYLSTEROIDS

Publications (2)

Publication Number Publication Date
IS7339A true IS7339A (is) 2004-06-28
IS2740B IS2740B (is) 2011-06-15

Family

ID=8185555

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7339A IS2740B (is) 2002-01-21 2004-06-28 Forskautsbygging rafgreiningarkera til þess að framleiða ál með tilheyrandi kerskála

Country Status (28)

Country Link
US (2) US20050090476A1 (is)
EP (1) EP1470151B1 (is)
JP (1) JP5250174B2 (is)
KR (1) KR100937179B1 (is)
CN (1) CN100372864C (is)
AR (1) AR038165A1 (is)
AT (1) ATE453659T1 (is)
AU (1) AU2003205604B8 (is)
BR (1) BRPI0306736B8 (is)
CA (1) CA2472379C (is)
DE (1) DE60330749D1 (is)
EC (1) ECSP045180A (is)
EG (1) EG23417A (is)
ES (1) ES2336439T3 (is)
HR (1) HRP20040634B1 (is)
IL (2) IL162770A0 (is)
IS (1) IS2740B (is)
MX (1) MXPA04007049A (is)
NO (1) NO327095B1 (is)
NZ (1) NZ533970A (is)
PE (1) PE20030926A1 (is)
PL (1) PL208163B1 (is)
RO (1) RO122913B1 (is)
RS (1) RS51490B (is)
RU (1) RU2305105C2 (is)
TW (1) TWI322813B (is)
WO (1) WO2003059931A1 (is)
ZA (1) ZA200405257B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10213371C1 (de) * 2002-03-21 2003-12-24 Schering Ag Verfahren zur Herstellung von 7alpha-Methylsteroiden
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
KR100716981B1 (ko) * 2004-09-30 2007-05-10 삼성전자주식회사 대중교통의 최적경로 검색방법 및 이를 이용한 휴대용 기기
JP5749261B2 (ja) * 2009-06-29 2015-07-15 メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー 3,3,5,5−テトラメチルシクロヘキサノンを調製する方法
CN111944001A (zh) * 2020-07-09 2020-11-17 浙江神洲药业有限公司 一种替勃龙的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341557A (en) * 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
US3470216A (en) * 1966-11-29 1969-09-30 Du Pont Selected 17,17-difluoro unsaturated androstanes
FR2054527B1 (is) * 1969-07-28 1973-06-08 Roussel Uclaf
US3798213A (en) * 1971-01-25 1974-03-19 Merck & Co Inc 7 alpha-methyl-20-spiroxane-3-ones and process
DE2558088C2 (de) * 1975-12-19 1985-05-30 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 4-Androsten-3,17-dion-Derivaten
JPS56145239A (en) * 1980-04-11 1981-11-11 Sumitomo Chem Co Ltd Novel bicyclooctane derivative and its preparation
US4298559A (en) * 1980-07-23 1981-11-03 Dow Corning Corporation High yield silicon carbide from alkylated or arylated pre-ceramic polymers
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6548491B2 (en) * 1997-12-24 2003-04-15 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
TW548277B (en) * 1999-07-16 2003-08-21 Akzo Nobel Nv Orally active androgens
IL149424A (en) * 1999-12-02 2007-05-15 Organon Nv Androgens are converted to methylene at positions 15,14
WO2001058919A2 (en) * 2000-02-11 2001-08-16 Sri International Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one
AU8201601A (en) * 2000-07-28 2002-02-13 Akzo Nobel Nv 16alpha-methyl or ethyl substituted estrogens
US20040010138A1 (en) * 2002-03-21 2004-01-15 Schering Ag Process for the production of 7alpha-methyl steroids
US7304157B2 (en) * 2004-09-28 2007-12-04 Bristol-Myers Squibb Company Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

Also Published As

Publication number Publication date
NZ533970A (en) 2005-10-28
US20050090476A1 (en) 2005-04-28
IL162770A (en) 2011-06-30
CA2472379C (en) 2010-05-25
RO122913B1 (ro) 2010-04-30
EG23417A (en) 2005-06-28
US20100204497A1 (en) 2010-08-12
CA2472379A1 (en) 2003-07-24
IL162770A0 (en) 2005-11-20
ZA200405257B (en) 2005-08-31
ECSP045180A (es) 2004-08-27
NO327095B1 (no) 2009-04-20
TWI322813B (en) 2010-04-01
JP2005519899A (ja) 2005-07-07
AU2003205604B2 (en) 2009-11-26
WO2003059931A1 (en) 2003-07-24
AU2003205604B8 (en) 2009-12-24
JP5250174B2 (ja) 2013-07-31
BR0306736A (pt) 2004-12-28
AU2003205604A1 (en) 2003-07-30
BRPI0306736B1 (pt) 2017-11-07
RS51490B (sr) 2011-04-30
RU2305105C2 (ru) 2007-08-27
DE60330749D1 (de) 2010-02-11
HRP20040634B1 (hr) 2013-07-31
EP1470151B1 (en) 2009-12-30
NO20043455L (no) 2004-08-19
KR100937179B1 (ko) 2010-01-19
ATE453659T1 (de) 2010-01-15
MXPA04007049A (es) 2004-10-14
ES2336439T3 (es) 2010-04-13
PL371583A1 (en) 2005-06-27
TW200302731A (en) 2003-08-16
EP1470151A1 (en) 2004-10-27
PL208163B1 (pl) 2011-03-31
KR20040077727A (ko) 2004-09-06
CN100372864C (zh) 2008-03-05
CN1863814A (zh) 2006-11-15
IS2740B (is) 2011-06-15
PE20030926A1 (es) 2003-10-29
HRP20040634A2 (en) 2004-10-31
RU2004125580A (ru) 2006-01-27
AR038165A1 (es) 2004-12-29
YU63004A (sh) 2006-08-17
BRPI0306736B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
HK1085192A1 (en) Method for producing light gypsum board
DE60205413D1 (de) Herstellungsverfahren
IS8122A (is) Aðferð til að framleiða N-útskipt 2-sýanópýrrólídín
EP1484384A4 (en) PROCESS FOR PRODUCING BIOCARBURANT
IS7981A (is) Aðferð til að framleiða örkerfi
FI20021560A (fi) Ohjausmenetelmä
PL1697390T3 (pl) Sposób wytwarzania organoacylofosforynów
IL173238A0 (en) Methods for producing tetrabromobenzoate esters
EP1634958A4 (en) PROCESS FOR PRODUCING OPTICALLY ACTIVE CHROMAN CARBOXYLATE
IS7339A (is) Aðferð til framleiðslu á 7alfa-metýlsterum
NO20043760L (no) Fremgangsmate til fremstilling av olefiner
NO20035626D0 (no) Metode
NO20035401D0 (no) Metode
HK1133870A1 (en) Method for producing 4-pentafluoride-sulfanyl-benzoylguanidines
DE10394362D2 (de) Method for the operation of a technical system
FI20030381A0 (fi) Menetelmä prosessin säätämiseksi
EP1556396A4 (en) METHOD OF PRODUCING 2-DESOXY-L-RIBOSE
ITMI20021432A0 (it) Metodo per produrre cefalosporine
IS8088A (is) Aðferð til að framleiða imídasópýridín-8-ón
PL372169A1 (en) Method for producing gelatin
IS7450A (is) Aðferð til framleiðslu á sertindóli
NO20035692D0 (no) Produksjonsmetode
FI20021421A0 (fi) Valmistusmenetelmä
FI20022301A (fi) Asettamismenetelmä
ITMI20042151A1 (it) Procedimento per produrre acquavite